Skip to main content

Avanos Medical, Inc.

AVNSDelisted Jul 27, 2026
Industry
Orthopedic, Prosthetic & Surgical Appliances & Supplies
SEC CIK
0001606498

Avanos Medical, Inc. was delisted on Jul 27, 2026; its insiders filed their last Form 4 on Jul 28, 2026; 290 institutions reported holding it in 13F filings for Q2 2026, worth $1.08B in total; no superinvestor held it.

Key figures

Market cap
–
Not available
Insider buys
0
Open market, last 90 days
Insider sells
0
Open market, last 90 days
13F holders
290
Q2 2026, +31 vs. previous quarter
13F value
$1.08B
Reported value at the end of Q2 2026
Superinvestors holding
0
At the end of Q2 2026

From SEC filings, in USD.

Revenue, FY2025
$701.2M
+1.9% year over year
Net income, FY2025
-$72.9M
No comparable prior period
Free cash flow, FY2025
$43.1M
−48.0% year over year
Revenue, Q1 FY2026
$182.2M
+8.8% year over year

Revenue flow, FY2025

Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue.

Net loss for FY2025: $72.9M (10.4% of revenue).

Short interest

See short data

From FINRA, settlement date Jul 15, 2026.

Short interest
1.75M
Shares sold short
Change
−23.2K
−1.3% vs. previous
Days to cover
2.35
At average daily volume

Superinvestors holding AVNS, Q2 2026

Go to the superinvestors tab

No superinvestor reported holding AVNS at the end of Q2 2026.

Latest insider trades

See all insider trades

Open-market purchases and sales by Avanos Medical, Inc. insiders from Form 4, newest first.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Nov 19, 2025 (view filing)Nov 181 dayHolbrook KerrSVP, Chief Commercial OfficerSSale−15.0K$11.00−$165.0K−15.2%83.9K after4 lots
Aug 15, 2025 (view filing)Aug 132 daysBlackford GaryDirectorPPurchase+20.0K$10.98+$219.6K+27.9%91.6K after
Aug 15, 2025 (view filing)Aug 132 daysBlackford GaryDirectorPPurchase+40.0K$11.00+$440.0KNew position40.0K after
Mar 10, 2025 (view filing)Mar 64 daysHolbrook KerrSVP, Chief Commercial OfficerSSale−7.00K$15.25−$106.8K−7.9%82.0K after
Mar 15, 2024 (view filing)Mar 141 dayGreiner MichaelSVP - Chief Financial OfficerSSale−8.00K$19.12−$153.0K−5.0%151.5K after6 lots
Mar 11, 2024 (view filing)Mar 11Same dayShimer Julie AnnDirectorPPurchase+500$19.85+$9.93K+1.0%50.1K after
Sep 16, 2021 (view filing)Sep 151 dayOleary Patrick JDirectorPPurchase+5.00K$31.63+$158.1K+17.3%33.9K after4 lots

Top 10 13F holders, Q2 2026

See all 290 holders

The largest institutional positions in Avanos Medical, Inc. at the end of Q2 2026; share changes are against Q1 2026.

Institutions holding AVNS in Q2 2026
InstitutionSharesValue% of portfolioChange in sharesAction
BlackRock, Inc.7,468,794$185.8M0.00%+625,061+9.1%Added
Highland Capital Management Fund Advisors, L.P.2,177,366$54.2M3.62%+2,177,366New
State Street Corp2,010,691$50.0M0.00%+38,168+1.9%Added
Vanguard Capital Management LLC1,993,794$49.6M0.00%+21,829+1.1%Added
TIG Advisors, LLC1,668,329$41.5M1.91%+1,668,329New
Millennium Management LLC1,524,553$37.9M0.03%+1,510,727+10,926.7%Added
Vivaldi Asset Management, LLC1,184,190$29.5M1.72%+1,184,190New
Geode Capital Management, LLC1,181,164$29.4M0.00%+86,929+7.9%Added
JPMorgan Chase & Co1,099,770$27.4M0.00%+848,608+337.9%Added
Charles Schwab Investment Management Inc946,344$23.5M0.00%−111,722−10.6%Reduced

Holders of 5% or more of AVNS

See all 2 holders and filings

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Avanos Medical, Inc..

Largest holders of AVNS from 13D and 13G filings
HolderLatest formStakeChangeFirst filedLatest filingFiling
BlackRock, Inc.13G/A14.80%6.83M shares–Apr 30, 20251 filingApr 30, 2025SEC
Vanguard Capital Management LLC13G5.00%2.34M sharesNewJul 31, 20261 filingJul 31, 2026SEC

1 member of Congress reported 1 trade in Avanos Medical, Inc. since 2020. Newest filings:

  1. Van Taylor

    House · TX · Apr 13, 2020

    Sell$1K-$15K